Glucocorticoid feedback resistance

Trends in Endocrinology and Metabolism

Volumn 8, Issue 1, 1997, Pages 26-33

  De Kloet, E Ronald ^a   Vreugdenhil, Erno ^a   Oitzl, Melly S ^a   Joëls, Marian ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; VASOPRESSIN;

ADRENAL CORTEX FUNCTION; FEEDBACK SYSTEM; GENETIC PREDISPOSITION; HIPPOCAMPUS; HORMONE RESISTANCE; HUMAN; HYPERADRENOCORTICISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0031058449     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(96)00205-6     Document Type: Review

References (65)

1. Akana SF, Dallman MF Feedback and facilitation in the adrenocortical system: unmasking facilitation by partial inhibition of the glucocorticoid response to prior stress. Endocrinology. 131:1992;57-68.
2. Antoni FA Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol. 14:1993;76-122.
3. Bamberger CB, Bamberger AM, De Castro Met al. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest. 95:1995;2435-2441.
4. Bamberger CB, Schulte HM, Chrousos GP Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 17:1996;245-261.
5. Barden N, Reul JMHM, Holsboer F Do anti-depressants stabilize mood on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18:1995;6-14.
6. Barnes PJ, Adcock I Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 14:1993;436-441.
7. Bohus B, Benus RF, Fokkema DSet al. Neuroendocrine states and behavioral and physiological responses. Prog Brain Res. 72:1987;57-71.
8. Bourgeois S, Groul D, Newby Ret al. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol. 7:1993;840-851.
9. Bradbury M, Akana SF, Dallman MF Roles of Type 1 and Type 2 corticosteroid receptors in the regulation of basal activity in the hypothalamic-pituitary-adrenal axis during the diurnal trough and peak: evidence for a non-additive effect of combined receptor occupation. Endocrinology. 134:1994;1286-1296.
10. Brönneg̊ard M, Carlstedt-Duke J The genetic basis of glucocorticoid resistance. Trends Endocrinol Metab. 6:1995;160-164.
11. Brönneg̊ard M, Stierna P, Marcus C Glucocorticoid-resistant syndromes: molecular basis and clinical presentations. J Neuroendocrinol. 8:1996;405-415.
12. Carey MP, Deterd CH, De Koning Jet al. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation. J Endocrinol. 144:1995;311-321.
13. Chan-Palay V, Kohler C: 1989. The Hippocampus: New Vistas. Neurology and Neurobiology, vol. 52. New York, Alan Liss.
14. Chrousos GP The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 332:1995;1351-1359.
15. Cidlowski JA, Oakley RH, Webster JC, et al.: 1996. Characterization and regulation of the beta isoform of the human glucocorticoid receptor [abst P2-847]. In Proceedings of the 70th Annual Meeting of the Endocrine Society, San Francisco, CA, p 616.
16. Cole TJ, Blendy JA, Monaghan APet al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9:1995;1608-1621.
17. Dallman MF Stress update: adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress. Trends Endocrinol Metab. 4:1993;62-69.
18. Dallman MF, Akana SF, Scribner KAet al. Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol. 4:1992;517-526.
19. De Kloet ER Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol. 12:1991;95-164.
20. De Kloet ER, Joëls M Corticosteroid hormones in neuroprotection and brain damage. Curr Opin Endocrinol. 3:1996;184-192.
21. Feldman S, Weidenfeld J Neural mechanisms involved in the corticosteroid feedback effects on the hypothalamo-pituitary-adrenocortical axis. Prog Neurobiol. 45:1994;129-141.
22. Funder JW Commentary: the tale of the guinea pig. Front Neuroendocrinol. 15:1994;384-389.
23. Griep ED, Boersma JW, De Kloet ER Altered reactivity of the hypothalamic-pituitary-adrenal activity in the fibromyalgia syndrome. J Rheumatol. 20:1993;469-474.
24. Herman JP, Adams D, Prewitt C Regulatory changes in neuroendocrine stress integrative circuitry produced by a variety of stress paradigms. Neuroendocrinology. 61:1995;180-190.
25. Holsboer F, Barden N Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev. 17:1996;187-205.
26. Holsboer F, Lauer CJ, Schreiber Wet al. Altered hypothalamic-pituitary-adrenal regulation in healthy subjects at high familial risk for depression. Neuroendocrinology. 62:1995;340-347.
27. Hurley DM, Accili D, Stratakis CAet al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest. 87:1991;680-686.
28. Joëls M, De Kloet ER Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 15:1992;25-30.
29. Joëls M, De Kloet ER Mineralocorticoid and glucocorticoid receptors in the brain: implications for ion permeability and transmitter systems. Prog Neurobiol. 43:1994;1-36.
30. Kam JC, Szefler SJ, Surs Wet al. Combination of IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T cell response to glucocorticoid therapy. J Clin Invest. 93:1993;33-39.
31. Karl M, Lamberts SWJ, Detera-Wadleigh SD Familial glucocorticoid resistance caused by a splice deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab. 76:1993;683-689.
32. Keigthly MC, Fuller PJ Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity. Mol Endocrinol. 8:1994;431-439.
33. Korte SM, De Boer SF, De Kloet ERet al. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in elevated plus maze. Psychoneuroendocrinology. 20:1995;385-394.
34. Lamberts SWJ, Koper JW, Biemond Pet al. Cortisol receptor resistance: the variability of clinical presentation and response to treatment. Clin Endocrinol Metab. 74:1992a;313-321.
35. Lamberts SWJ, Koper JW, De Jong FH Long-term treatment with RU 486 and glucocorticoid receptor resistance: theoretical and therapeutical implications. Trend Endocrinol Metab. 3:1992b;199-205.
36. Levine S The ontogeny of the hypothalamic-pituitary-adrenal axis: the influence of maternal factors. Ann NY Acad Sci. 746:1994;275-293.
37. Malchoff CD, Malchoff DM Glucocorticoid resistance in man. Trends Endocrinol Metab. 6:1995;89-94.
38. McEwen BS Glucocorticoid-biogenic amine interaction in relation to mood and behavior. Biochem Pharmacol. 36:1987;1755-1763.
39. McEwen BS, Sapolsky RM Stress and cognitive function. Curr Opin Neurobiol. 5:1995;205-217.
40. Meaney MJ, Aitken DH, Van Berkel Cet al. Effect of neonatal handling on age-related impairments associated with hippocampus. Science. 239:1988;766-768.
41. Molijn GM, Spek JJ, Van Uffelen CJCet al. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear, leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab. 80:1995;1799-1803.
42. Munck A, McGuire PM, Holbrook NJ Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 5:1984;25-44.
43. Oitzl MS, De Kloet ER Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci. 106:1992;62-71.
44. Oitzl MS, Van Haarst AD, Sutanto Wet al. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology. 20:1995;655-677.
45. Pfahl M Nuclear/receptor AP-1 interaction. Endocr Rev. 14:1993;651-658.
46. Piazza PV, Maccari S, Deminiere JMet al. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA. 88:1991;2088-2092.
47. Plotsky P Pathways to the secretion of adrenocorticotropin: a view from the portal. J Neuroendocrinol. 3:1991;1-9.
48. Ratka A, Sutanto W, Bloemers Met al. On the role of brain mineralocorticoid (type 1) and glucocorticoid (type 2) receptors in neuroendocrine regulation. Neuroendocrinology. 50:1989;117-123.
49. Roland BL, Krozowski ZL, Funder JW Glucocorticoid receptor, mineralocorticoid receptor, 11β-hydroxysteroid dehydrogenase-1 and -2 in rat brain and kidney: in situ studies. Mol Cell Endocrinol. 28:1995;R1-R7.
50. Romero LM, Sapolsky RM Patterns of ACTH secretagogue secretion in response to psychological stimuli. J Neuroendocrinol. 8:1996;243-258.
51. Rots NY, De Jong J, Workel JO Neonatally deprived rats have as adults elevated basal pituitary-adrenal activity and enhanced susceptibility to apomorphine. J Neuroendocrinol. 8:1996a;501-506.
52. Rots NY, Cools AR, Oitzl MSet al. Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness. Endocrinology. 137:1996b;1678-1686.
53. Sapolsky RM: 1992. Stress, the Aging Brain and the Mechanism of Neuron Death. Cambridge, MA, MIT Press.
54. Schöbitz B, Sutanto W, Carey MPet al. Endotoxin and interleukin-1 decrease the affinity of hippocampal mineralocorticoid (type 1) receptor parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology. 60:1994;124-133.
55. Stratakis CA, Karl M, Schulte Het al. Glucocorticoid resistance in humans: elucidation of the molecular mechanisms and implications for pathophysiology. Ann NY Acad Sci. 746:1994;362-377.
56. Swanson LW Biochemical switching in hypothalamic circuits mediating responses to stress. Prog Brain Res. 87:1991;181-200.
57. Van Dijken HH, De Goeij DCE, Sutanto Wet al. Short inescapable stress produces long-lasting changes in the brain-pituitary-adrenal axis of adult male rats. Neuroendocrinology. 58:1993;57-64.
58. Van Eekelen JAM, Oitzl MS, De Kloet ER Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old Brown Norway rats. J Gerontol. 50A:1995;B83-B89.
59. Van Haarst AD, Welberg LAM, Sutanto Wet al. 11β-hydroxysteroiddehydrogenase in the hippocampus: implications for corticosterone binding and nuclear retention. J Neuroendocrinol. 8:1996a;595-600.
60. Van Haarst AD, Oitzl MS, Workel JO, De Kloet ER Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology. 137:1996b;4935-4943.
61. Wolkowitz OM Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 19:1994;233-255.
62. Yau JLW, Seckl JR Corticosteroids and the brain. Curr Opin Endocrinol. 2:1995;239-247.
63. Yau JLW, Olsson T, Morris RGM (et. al) Glucocorticoids, hippocampal corticosteroid receptor gene expression and anti-depressant treatment. Relationship with spatial learning in young and aged rats. Neurosci. 66:1995;571-581.
64. Yehuda R Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology. 21:1996;1-16.
65. Zhang Y, Bai W, Allgood VEet al. Multiple signaling pathways activate the chicken progesterone receptor. Mol Endocrinol. 8:1994;577-585.